Dr. Puja Shikhaliya
About Dr. Puja Shikhaliya
Dr. Puja Shikhaliya is a Pharmacovigilance Specialist with over three years of experience in drug safety and pharmacovigilance. She currently works at ConnectiveRx in Whippany, New Jersey, and has previously served as a Licensed Pharmacy Technician at CVS Health.
Work at ConnectiveRx
Dr. Puja Shikhaliya has been employed at ConnectiveRx as a Pharmacovigilance Specialist since 2023. In this role, she focuses on ensuring the accuracy of event MedDRA term coding, seriousness assessment, case validity, and special case scenarios. Her responsibilities include utilizing the ORACLE ARGUS Safety database for case processing, which is essential for maintaining drug safety and pharmacovigilance standards.
Previous Experience at CVS Health
Prior to her current position, Dr. Shikhaliya worked at CVS Health as a Licensed Pharmacy Technician from 2022 to 2023. During her four-month tenure in New Jersey, she gained valuable experience in the pharmacy sector, contributing to her expertise in pharmacovigilance and drug safety.
Education and Expertise
Dr. Shikhaliya earned her Bachelor of Homeopathic Medicine and Surgery from Saurashtra University in Rajkot, where she studied from 2005 to 2011. This educational background has provided her with a solid foundation in medical knowledge, which she applies in her current role as a Pharmacovigilance Specialist.
Pharmacovigilance Skills
Dr. Shikhaliya specializes in pharmacovigilance and drug safety, with over three years of experience in the medical and health sector. She is proficient in using MedDRA and the WHO Drug dictionary for data coding, including adverse event and drug coding. Her skills also include participating in audits and inspections to ensure compliance with quality and regulatory standards.
Contributions to Industry Standards
In her role, Dr. Shikhaliya actively contributes to maintaining and updating local processes, procedures, and systems to align with current industry standards and best practices. This involvement is crucial for enhancing the quality of pharmacovigilance practices within her organization.